Trump administration releases White House analysis estimating $529 billion in savings from pharmaceutical price negotiations over 10 years

The White House Council of Economic Advisers released projections estimating that President Trump's deals with pharmaceutical companies to align U.S. prescription drug prices with those in other countries would save the economy $529 billion over the next decade. The analysis was obtained by the Associated Press and represents the first economy-wide projection behind a core Trump policy aimed at voters ahead of midterm elections. Democratic lawmakers have expressed skepticism about the savings claims.